仕佳光子：拟发行股份及支付现金购买福可喜玛股权并募资

Core Viewpoint - The company plans to acquire equity in Fokexima through a combination of issuing shares and cash payment, which is expected to constitute a related party transaction but does not qualify as a major asset restructuring or a restructuring listing [1] Group 1 - The company's stock will resume trading on July 11, 2025 [1] - As of December 30, due to incomplete due diligence, auditing, and evaluation, the company is unable to convene a shareholder meeting within the stipulated timeframe [1] - The company will continue to advance the transaction and negotiate details, with a board meeting planned for further review [1] Group 2 - The transaction requires multiple processes to be completed, and there is uncertainty regarding its final implementation [1]